CRMT
America's Car-Mart, Inc.
There isn't enough reported data to score CRMT yet.
NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
CRMT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Healthy | |
| Strong |
CRMT's cash flow and balance sheet are currently healthy, but its revenue and profitability are weak.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CRMT PE Valuation
CRMT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 1.1x next year's earnings.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
CRMT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
CRMT has the edge over NKE on the outlook, with more favorable earnings expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CRMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q3 2026 | -$24.38 | -1462% |
| Q2 2026 | -$16.79 | -821% |
| Q1 2026 | -$11.15 | -1312% |
| Q4 2025 | -$1.53 | -$0.74 |
| Q3 2025 | $1.79 | +$7.49 |
| Q2 2025 | $2.33 | +$7.25 |
| Q1 2025 | $0.92 | +$5.60 |
| Q4 2024 | -$0.79 | +$2.32 |
CRMT has swung to a loss: it lost $24.38 per share over the past year, after a profit the year before.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over CRMT on earnings quality, reporting a profit while its opponent remains loss making.
CRMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $145.8M | -57% |
| Q2 2026 | $302.8M | -18% |
| Q1 2026 | $286.8M | -12% |
| Q4 2025 | $350.2M | +0.8% |
| Q3 2025 | $341.3M | -1.9% |
| Q2 2025 | $370.2M | +1.5% |
| Q1 2025 | $325.7M | +8.7% |
| Q4 2024 | $347.3M | -4% |
CRMT's revenue has slid since its 2023 peak: $146M last quarter, down 57% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -47% | -45 points |
| Q2 2026 | -12% | -15 points |
| Q1 2026 | -13% | -14 points |
| Q4 2025 | -7.8% | -9.9 points |
| Q3 2025 | -2.2% | -1.8 points |
| Q2 2025 | 3.4% | +3.2 points |
| Q1 2025 | 1.4% | +4.8 points |
| Q4 2024 | 2% | +12 points |
CRMT's operating margin was −47% last quarter, down 45 points from the same quarter a year ago, near the bottom of its range since 2019.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over CRMT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over CRMT on profitability, with a higher operating margin.
CRMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $80M | +$86.4M |
| Q2 2026 | $67.4M | +266% |
| Q1 2026 | -$6.2M | +$25.3M |
| Q4 2025 | $8.3M | +$31.9M |
| Q3 2025 | -$6.4M | +$9.6M |
| Q2 2025 | $18.4M | +$30.4M |
| Q1 2025 | -$31.5M | -408% |
| Q4 2024 | -$23.6M | +$7.9M |
CRMT has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
CRMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +40.2K shares |
| 1 year | +0.7% | +55.5K shares |
| 3 years | +26% | +1.7M shares |
| 5 years | +19% | +1.3M shares |
| Available history | +20% | +1.4M shares |
CRMT has 8M diluted shares, up 0.7% from a year ago, despite $255,000 in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25,000 |
| Q2 2026 | $2,000 |
| Q1 2026 | $23,000 |
| Q4 2025 | $205,000 |
| Q3 2025 | $71,000 |
| Q2 2025 | $2,000 |
| Q1 2025 | $20,000 |
| Q4 2024 | $388,000 |
CRMT spent $255,000 buying back its own shares over the past year, down 47% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over CRMT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
CRMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2023 | -0.3x | Net Cash |
| Q2 2023 | 5.1x | High |
| Q4 2022 | 3.5x | Elevated |
| Q3 2022 | 1.7x | Healthy |
CRMT has more cash than debt.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
CRMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.1 | Oversold |
| Stochastic | 18.7 | Oversold |
CRMT's weekly RSI is 28 (oversold) and its Stochastic is 19 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CRMT PE vs Consumer Cyclical Sector
| Metric | CRMT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CRMT has no meaningful PE right now: it lost money over the past year.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
CRMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.09 | 15% below |
| 20 week MA | $2.09 | 56% below |
| 50 week MA | $11.0 | 92% below |
| 100 week MA | $27.0 | 97% below |
| 200 week MA | $49.6 | 98% below |
CRMT is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over CRMT on trend strength, trading above more of its moving averages.
CRMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.6 | $110.0 | +1.3% |
| 2021 | $110.0 | $102.8 | -6.5% |
| 2022 | $102.8 | $72.1 | -30% |
| 2023 | $72.1 | $75.8 | +5.1% |
| 2024 | $75.8 | $52.3 | -31% |
| 2025 | $52.3 | $25.9 | -51% |
| 2026 YTD | $25.9 | $0.93 | -96% |
CRMT has finished lower in four of the last six years. It's down 96% so far in 2026.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over CRMT on returns for 2026, with the stronger performance.